Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix.

International journal of cancer - 1 Jun 1994

Honma S, Tsukada S, Honda S, Nakamura M, Takakuwa K, Maruhashi T, Kodama S, Kanazawa K, Takahashi T, Tanaka K

Abstract excerpt

To determine possible correlations between the selective loss of HLA-class-I allelic forms on neoplastic cells and their biological-clinical characteristics, 89 squamous-cell carcinomas of the uterine cervix were evaluated immunohistochemically using monomorphic and polymorphic antibodies against HLA-A, -B, and -C molecules and analyzed clinico-pathologically. Four of the carcinomas exhibited a lack of detectable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Histocompatibility Antigens Class I

Share to Immunohistochemistry

Share to Lymphatic Metastasis

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 8194872
DOI: 10.1002/ijc.2910570507

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix.PMID 8194872Read ↗

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.Semantic proximity Read ↗

The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.Semantic proximity Read ↗

Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.Semantic proximity Read ↗

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.Semantic proximity Read ↗

Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma.Semantic proximity Read ↗

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.Semantic proximity Read ↗

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.Semantic proximity Read ↗

Multiple mechanisms underlie HLA dysregulation in cervical cancer.Semantic proximity Read ↗

Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.Semantic proximity Read ↗

High frequency of HLA-B44 allelic losses in human solid tumors.Semantic proximity Read ↗

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.Semantic proximity Read ↗

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.